Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597025 · ClinicalTrials.gov registry record · NA
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
A NA study, sponsored by Satellite Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 375
- Enrollment target
NCT00597025: Completed NA study, sponsored by Satellite Healthcare.
NCT00597025 is a NA study that has completed, run by Satellite Healthcare. The registered enrollment target is 375 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597025, a NA study, has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
Study Summary
This study is to evaluate the impact of providing high protein supplementation in the form of a medical food bar containing 20grams of protein eath to hypoalbuminemic dialysis patients.
Interventions
- DIETARY_SUPPLEMENT Protein Food Bar Intelligent Indulgence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00597025 record still lists
NCT00597025 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which Protein Food Bar Intelligent Indulgence is the first listed.
NCT00597025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00597025 about?
NCT00597025 is a clinical study titled "Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin". This study is to evaluate the impact of providing high protein supplementation in the form of a medical food bar containing 20grams of protein eath to hypoalbuminemic dialysis patients.
What is the current status of trial NCT00597025?
This trial is currently completed. It is a NA study. The enrollment target is 375 participants. The study started on 2007-12. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00597025?
The interventions under investigation include: Protein Food Bar Intelligent Indulgence (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00597025?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00597025's enrollment target sits among peer trials
375 276th of 2000 higher than 1,721 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia